gip glp 1 receptor agonist Dual GIP/GLP-1 agonists: New advances for treating type-2 diabetes LY3437943, a novel triple glucagon,

When prescribed and monitored by licensed medical professionals, peptide therapy is generally well-tolerated with minimal side effects

Biological activities of thymosin 4 defined by active sites in short peptide sequences

A theoretical model based upon mast cells and histamine to explain the recently proclaimed sensitivity to electric and/or magnetic fields in humans

Activation of the GH/IGF-1 axis by CJC-1295, a long acting GHRH analog, results in serum protein profile changes in normal adult subjects

found that partial weight reduction protocols led to quicker average weight loss compared to complete protocols, which might be more appropriate for older cats or those with severe obesity

elevated fasting insulin indicates strong tirzepatide candidacy